MED9 Antikörper (AA 55-146) (FITC)
Kurzübersicht für MED9 Antikörper (AA 55-146) (FITC) (ABIN8008720)
Target
Alle MED9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 55-146
-
Verwendungszweck
- Anti-MED9 Antibody FITC Conjugated
-
Spezifität
- No cross reactivity with other proteins.
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E. coli-derived human MED9 recombinant protein (Position: A55-E146).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- MED9 (Mediator Complex Subunit 9 (MED9))
-
Andere Bezeichnung
- MED9
-
Hintergrund
-
Background: MED9 is a member of the mediator complex of proteins that promote activation of RNA polymerase II through interactions with transcription factors. This MED9gene is located within the Smith-Magenis syndrome region on chromosome 17.
Gene Full Name: mediator complex subunit 9
-
Gen-ID
- 55090
-
UniProt
- Q9NWA0
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-